The mission of the Alzheimer’s Association Business Consortium (AABC) is to advance Alzheimer’s disease research and innovation in small- and medium-size biotechnology, diagnostics, medical device and contract research organizations.

AABC members work in areas of common interest pre-competitively to advance both the field of Alzheimer’s research and the goals of its member organizations. They provide leadership and direction to the group’s areas of focus, which include, but are not limited to, collaborations, recognition and visibility, and knowledge and information sharing.

The AABC welcomes new members who are aligned in its commitment to research and innovation. To express interest in joining, email Dr. Leen Kawas, co-chair; Dr. Judy Walker, co-chair; or Dr. Rebecca Edelmayer, facilitator.

 

Collaborations

Collaborations are very valuable to small companies as a way to share resources, expand infrastructure, save money and potentially create income. The consortia will provide a platform for companies looking for collaboration opportunities within the consortia between member companies. The Alzheimer’s Association will provide a space on its web-site for the consortia companies to share information and develop relationships. The consortia members will also share ideas on how to develop collaborations with large companies external to the consortia.

Recognition and visibility

Small companies will benefit from publications and positive publicity. As such, the AABC will look for ways to bring companies in this sector to the attention of the AD R&D community through publications and posters. As an example, the AABC may present a poster at an upcoming AAIC.

Knowledge and information sharing

The AABC will look for ways to share knowledge and information in a pre-competitive space. The group will share information about each member company. They may also share information on trusted consultants, CRO’s, ways to manage data in a small company, funding strategies and funding sources.

Consortium members

712 North
Acelot
Acumen Pharma​
ADMdx​
AI Cure
Alzeca Biosciences​
Amylyx
Araclon Biotech
Athira​
Aulesa
Bioexpert
BioEye
Blue Marble Medical
BrainBits​
Brain Spec
Capo Theraputics
Cenna Biosciences
Cerecin
Cognetivity Neurosciences
Cognition Therapeutics
Cognosci
CSRefresh
DiamiR
GaitIQ​
Genervon​
Hinge Bio
Hitchcock Regulatory Consulting
Imaginostics
InterVivo Solutions​
Intra-Cellular Therapies
Kenotech Labs
Keystone Bio
Lauren Sciences​
Longeveron
Multispan​
NanoSomiX
Neuro4D
NeuraMetrix
Neuronascent
NeuroScios
Neurotrack
Oasis Diagnostics

Presympto
ProMIS Neurosciences​
QMENTA 
QR Pharma
Septa Therapeutics
T3D Technologies
TAU BIO-LOGIC​
Telocyte
Tetra Discovery
Treventis

Meeting agendas and meeting minutes

July 15, 2019 Agenda (PDF)
Meeting minutes (PDF)
July 23, 2018 Agenda (PDF)
Meeting minutes (PDF)
February 15, 2018 Agenda (PDF)
Meeting minutes (PDF)
November 1, 2017 Agenda (PDF)
Meeting minutes (PDF)
February 1, 2017 Agenda (PDF)
Meeting minutes (PDF)
December 9, 2016 Meeting minutes (PDF)
October 19, 2015 Agenda (PDF)
Meeting minutes (PDF)
August 25, 2015 Agenda (PDF)
Meeting minutes (PDF)
July 21, 2015 Agenda (PDF)
Meeting minutes (PDF)
Questionnaire results (PDF)
May 13, 2015 Agenda (PDF)
Meeting minutes (PDF)
March 2, 2015 Agenda (PDF)
Meeting minutes (PDF)
November 18, 2014 Agenda (PDF)
Meeting minutes (PDF)

 

AABC webinars

Ask the Expert: CEO Panel - April 2019 (VIDEO)
NIA-AA Research Framework: Towards a Biological Definition of Alzheimer’s Disease - November 2018 (PDF)
Ask the Expert - August 2018 (PPT)
IR and PR Strategy for Emerging Alzheimer's Companies - June 2018 (PDF)
Ask The Expert - December 2017 (PDF)
AABC/ISTAART Joint Webinar - October 19, 2017 (PDF)
Ask The Expert - September 2017 (PPT)
Ask The Expert - June 2017 (PPT)
Ask The Expert - April 2017 (PPT)
SBIR/STTR funding for Alzheimer's disease (PDF)
What does pharma look for in evaluating companies as potential partners? (PDF)
Speaker: Declan Jones, Vice President, Neuroscience Lead, J&J Innovation Center; Wednesday, February 24, 2016 11:00 A.M. ET / 8:00 A.M. PT

AABC / ISTAART webinars

May 2017
Araclon ISTAART
Cytox Intro
DiamiR ISTAART
NanoSomiX ISTAART

May 2018
National Institute on Aging Small Business Award Program

Newsletters

Quarter 2 2019 newsletter
Quarter 1 2019 newsletter
Quarter 1 and 2 2018 newsletter
Quarter 3 2018 newsletter
Quarter 3 2017 newsletter
Quarter 2 2017 newsletter
Quarter 4 2017 newsletter
Quarter 3 2016 newsletter
Quarter 2 2016 newsletter
Quarter 4 2015 newsletter

Publications

Maximizing the Potential of Small Companies in Alzheimer’s Disease Research: Challenges and Opportunities (PPT)

Events

Upcoming events:
AABC Face to Face Meeting at AAIC 2019
Monday, 
July 15, 12 - 1:30 p.m.
JW Marriott, Georgia Room
Los Angeles

Past events:
The AABC Translation Animal Models Group, chaired by Joseph Araujo, InterVivo Solutions, and facilitated by Rebecca Edelmayer, Alzheimer’s Association, in collaboration with MODEL-AD members held a think tank in Washington, D.C., Nov. 28-29, 2018. The think tank was a shoulder meeting to the Alzheimer’s Association Research Roundtable and was well attended. The agenda consisted of sessions addressing proteomics, genomics and metabolomics, modern behavioral models, and translational, experimental and operational issues. The think tank proceedings will be submitted for publication. View the guest logistics or agenda for more information.

Get more information

For investigators who are interested in more information on the AABC, contact Rebecca Edelmayer, Ph.D.

Rebecca Edelmayer, Ph.D.
Director, Scientific Engagement
Medical & Scientific Relations
Alzheimer's Association
rmedelmayer@alz.org